Non-Invasive Prenatal Testing (NIPT) Market- - ...... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... Non-Invasive Prenatal Testing (NIPT) Market- Global Industry Analysis, Size, Share, ...

  • Published on
    20-Mar-2018

  • View
    217

  • Download
    4

Transcript

  • REPORT DESCRIPTION

    Non-Invasive Prenatal Testing (NIPT) Market Expected to Reach USD 3.62 Billion Globally in 2019: Transparency Market Research

    According to a new market report published by Transparency Market Research, "Non-

    Invasive Prenatal Testing (NIPT) Market (MaterniT21 PLUS, verifi, Harmony,

    Panorama, NIFTY, PrenaTest and BambniTest) - Global Industry Analysis, Size,

    Share, Growth, Trends and Forecast, 2013 - 2019" the global NIPT market was valued

    at USD 0.22 billion in 2012 and is expected to grow at a CAGR of 37.6% from 2013 to 2019,

    to reach an estimated value of USD 3.62 billion in 2019.

    The market for non-invasive prenatal testing is evolving rapidly due the advantages it offers

    over the conventional prenatal screening and diagnostic methods such as maternal serum

    screening, nuchal translucency (NT) scan, amniocentesis and chorionic villus sampling

    (CVS). These advantages include safety, accuracy, and no risk of miscarriage. An NIPT is a

    non-invasive genetic screening test for the common chromosomal abnormalities (trisomy

    21, trisomy 18, trisomy 13, monosomy X, etc.) observed in the fetuses of high risk

    Transparency Market Research

    Non-Invasive Prenatal

    Testing (NIPT) Market-

    Global Industry Analysis, Size, Share, Growth,

    Trends and Forecast, 2013 - 2019

    Single User License: US $ 4795

    Multi User License: US $ 7795

    Corporate User License: US $ 10795

    Buy Now Request Sample

    Published Date: Jan 2014

    68 Pages Report

    http://www.prnewswire.com/news-releases/non-invasive-prenatal-testing-nipt-market-expected-to-reach-usd-362-billion-globally-in-2019-transparency-market-research-238824411.htmlhttp://www.prnewswire.com/news-releases/non-invasive-prenatal-testing-nipt-market-expected-to-reach-usd-362-billion-globally-in-2019-transparency-market-research-238824411.htmlhttp://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.htmlhttp://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.htmlhttp://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.htmlhttp://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.htmlhttp://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.htmlhttp://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.htmlhttp://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.htmlhttp://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=374

  • pregnant women (above the age of 35 years). Owing to its ability to detect the presence of

    chromosomal abnormalities in fetuses of pregnant women as early as 9 to 10 weeks of

    gestation, the market for non-invasive prenatal testing market is witnessing a rapid

    increase in demand from all parts of the world.

    MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest are the

    commercially available NIPTs in the market which are based on the direct analysis of cell-

    free fetal DNA in the maternal blood. In 2012, MaterniT21 (a proprietary product of

    Sequenom, Inc.) accounted for the largest share (36.6%) of the global NIPT market in

    terms of revenue, owing to the fact that it was the first mover in the market place. During

    the forecast period 2013 to 2019, it is likely to lose some of its share due to increasing

    market penetration by other aforementioned NIPTs such as Panorama and verify.

    High incidence rate of babies born with certain type of chromosomal abnormalities, growing

    trend of child bearing at advanced maternal age and enhanced popularity of NIPT among

    gynecologists and high risk pregnant women are some of the major factors anticipated to

    drive growth of the NIPT market during the forecast period. Some of the most commonly

    detected chromosomal aneuploidies include Down syndrome, Edwards syndrome, Patau

    syndrome and monosomy X. On the other hand, ethical and regulatory hurdles are expected

    to pose significant challenges before the NIPT market to grow. Various professional

    committees across the world believe that the implementation of NIPT and the subsequent

    rise in uptake of prenatal testing is likely to increase the incidence of abortions. Therefore,

    professional groups such as The American College of Obstetricians and Gynecologists

    (ACOG), International Society for Prenatal Diagnosis and The Japan Society of Obstetrics

    and Gynecology have set up guidelines that limit the use of non-invasive prenatal testing

    only to pregnant women at high risk of chromosomal aneuploidies.

    Geographically, North America was the largest regional market in 2012 with a market share

    of 64.5% of the total revenue generated globally, followed by Europe. Almost every

    company operating in this market is adopting the same business model of marketing their

    tests via alliances with hospitals, diagnostic laboratories and physician offices. The

    increasing penetration by test developers in European, Asia-Pacific and Middle-East

    countries indicates promising growth in the near future in these markets. Sequenom, Inc.,

    Verinata Health, Inc. (now a part of Illumina, Inc.), Ariosa Diagnostics, Natera, Inc., BGI

    Health, LifeCodexx and Berry Genomics are the companies engaged in providing non-

    invasive prenatal tests worldwide.

    http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html

  • The global non-invasive prenatal testing market is segmented as follows:

    Non-Invasive Prenatal Testing Market, by Test

    MaterniT21 PLUS

    verifi

    Harmony

    Panorama

    NIFTY

    PrenaTest

    BambniTest

    Non-Invasive Prenatal Testing Market, by Geography

    North America

    Europe

    Asia-Pacific

    Rest of the World (RoW)

    TABLE OF CONTENT

    Chapter 1 Preface

    1.1 Report Description

    1.2 Market Segmentation

    1.3 Research Methodology

    1.3.1 Sources

    1.3.1.1 Secondary Research

    1.3.1.2 Primary Research

    1.3.2 Models

    Chapter 2 Executive Summary

  • Browse the full report with complete TOC:

    http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-

    market.html

    Chapter 3 Global Non-Invasive Prenatal Testing Market Overview

    3.1 Introduction

    3.2 Major Chromosomal Aneuploidies and their Incidence Rate

    3.2.1 Down Syndrome

    3.2.2 Edwards Syndrome

    3.2.3 Patau Syndrome

    3.2.4 Turner Syndrome

    3.2.5 Klinefelter Syndrome

    3.2.6 Jacobs Syndrome

    3.2.7 Triple X Syndrome

    3.3 Technological Approach for NIPT

    3.4 Market Drivers

    3.4.1 High incidence rate of babies born with Down syndrome

    3.4.2 Rise in average maternal age

    3.4.3 Increasing demand for early and non-invasive fetal testing procedures

    3.5 Market Restraints

    3.5.1 Regulatory guidelines and ethical hurdles

    3.5.2 Limitations of NIPT

    3.5.3 Availability of other screening and testing methods

    3.6 Market Opportunities

    3.6.1 Capitalizing on the potential presented by the emerging markets of Asia

    3.7 Porters Five Force Analysis for the Global Non-Invasive Prenatal testing Market

    3.7.1 Bargaining power of suppliers

    http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.htmlhttp://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html

  • 3.7.2 Bargaining power of buyers

    3.7.1 Threat of substitutes

    3.7.2 Threat of new entrants

    3.7.3 Competitive rivalry

    3.8 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by

    Geography

    Related & Recently Published Reports by Transparency Market Research

    Broadcast Switchers Market: http://www.transparencymarketresearch.com/broadcast-

    switchers-market.html

    Refrigerated Display Cases (Plug-in and Remote) Market:

    http://www.transparencymarketresearch.com/refrigerated-display-cabinets.html

    Physical Security (Hardware, Software and Services) Market:

    http://www.transparencymarketresearch.com/physical-security-market.html

    Anti-aging Market: http://www.transparencymarketresearch.com/anti-aging-market.html

    Teleradiology Market: http://www.transparencymarketresearch.com/teleradiology-

    technology-Market.html

    Chapter 4 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 -

    2019 (USD Million)

    4.1 Overview

    4.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 2019 (USD

    Million)

    4.1.2 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by

    Test, 2012 & 2019 (Value %)

    4.2 MaterniT21 PLUS

    4.2.1 Global MaterniT21 PLUS Test Market Revenue, 2012 2019 (USD Million)

    4.3 Harmony Prenatal Test

    4.3.1 Global Harmony Test Market Revenue, 2012 2019 (USD Million)

    4.4 verifi Prenatal Test

    4.4.1 Global verifi Test Market Revenue, 2012 2019 (USD Million)

    http://www.transparencymarketresearch.com/broadcast-switchers-market.htmlhttp://www.transparencymarketresearch.com/broadcast-switchers-market.htmlhttp://www.transparencymarketresearch.com/refrigerated-display-cabinets.htmlhttp://www.transparencymarketresearch.com/physical-security-market.htmlhttp://www.transparencymarketresearch.com/anti-aging-market.htmlhttp://www.transparencymarketresearch.com/teleradiology-technology-Market.htmlhttp://www.transparencymarketresearch.com/teleradiology-technology-Market.html

  • 4.5 Panorama Test

    4.5.1 Global Panorama Test Market Revenue, 2012 2019 (USD Million)

    4.6 Noninvasive Fetal Trisomy (NIFTY) Test

    4.6.1 Global NIFTY Test Market Revenue, 2012 2019 (USD Million)

    4.7 BambniTest

    4.7.1 Global BambniTest Test Market Revenue, 2012 2019 (USD Million)

    4.8 PrenaTest

    4.8.1 Global PrenaTest Test Market Revenue, 2012 2019 (USD Million)

    Chapter 5 Global Non-Invasive Prenatal Testing Market Revenue, by Geography,

    2012 - 2019 (USD Million)

    5.1 Overview

    5.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 -

    2019 (USD Million)

    5.1.2 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by

    Geography, 2012 & 2019 (Value %)

    5.2 North America

    5.2.1 North America Non-Invasive Prenatal Testing Market Revenue, 2012 - 2019 (USD

    Million)

    5.3 Europe

    5.3.1 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 - 2019 (USD Million)

    5.4 Asia-Pacific

    5.4.1 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 - 2019 (USD

    Million)

    5.5 Rest of the World (RoW)

    5.5.1 Rest of the World (RoW) Non-Invasive Prenatal Testing Market Revenue, 2012 -

    2019 (USD Million)

  • Chapter 6 Competitive Landscape

    6.1 Market Share Analysis, by Key Players, 2012 (%)

    Chapter 7 Recommendations

    7.1 Focus on improving technology in order to increase the accuracy, reduce the duration of

    result generation and price

    7.2 Focus on forming alliances with diagnostic service providers in European and Asia-Pacific

    countries

    7.3 Mergers and acquisitions

    Browse the full report with complete TOC:

    http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-

    market.html

    Chapter 8 Company Profiles

    8.1 Ariosa Diagnostics, Inc.

    8.1.1 Company Overview

    8.1.2 Product Portfolio

    8.1.3 Business Strategies

    8.1.4 Recent Developments

    8.2 Berry Genomics Co., Ltd

    8.2.1 Company Overview

    8.2.2 Product Portfolio

    8.2.3 Business Strategies

    8.2.4 Recent Developments

    8.3 BGI Health

    8.3.1 Company Overview

    http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.htmlhttp://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html

  • 8.3.2 Product Portfolio

    8.3.3 Business Strategies

    8.4 LifeCodexx AG

    8.4.1 Company Overview

    8.4.2 Product Portfolio

    8.4.3 Business Strategies

    8.4.4 Recent Developments

    8.5 Natera, Inc.

    8.5.1 Company Overview

    8.5.2 Product Portfolio

    8.5.3 Business Strategies

    8.5.4 Recent Developments

    8.6 Sequenom, Inc.

    8.6.1 Company Overview

    8.6.2 Financial Overview

    8.6.3 Product Portfolio

    8.6.4 Business Strategies

    8.6.5 Recent Developments

    8.7 Verinata Health, Inc.

    8.7.1 Company Overview

    8.7.2 Product Portfolio

    8.7.3 Recent Developments

  • About Us:

    Transparency Market Research is a market intelligence company providing global business

    information reports and services. Our exclusive blend of quantitative forecasting and trends

    analysis provides forward-looking insight for thousands of decision makers.

    We are privileged with highly experienced team of Analysts, Researchers and Consultants,

    who use proprietary data sources and various tools and techniques to gather, and analyze

    information. Our business offerings represent the latest and the most reliable information

    indispensable for businesses to sustain a competitive edge.

    Contact: Transparency Market Research 90 State Street, Suite 700, Albany,NY 12207, United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453

    Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse the full report with complete TOC:

    http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-

    market.html

    Related Blogs: https://vaibhavmondhe.wordpress.com

    https://usamarketresearch.wordpress.com/

    https://pharmaceuticalmarkets.wordpress.com/

    https://medicaldevicesreports.wordpress.com/ https://chemicalandmaterials.wordpress.com/

    mailto:sales@transparencymarketresearch.com?subject=%20Sales%20Inquiryhttp://www.transparencymarketresearch.com/http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.htmlhttp://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.htmlhttps://vaibhavmondhe.wordpress.com/https://usamarketresearch.wordpress.com/https://pharmaceuticalmarkets.wordpress.com/https://medicaldevicesreports.wordpress.com/https://chemicalandmaterials.wordpress.com/

Recommended

View more >